Trade Amgen ^AMGN

Amgen CEO: weight loss drug can address 'patient persistence issue'

Ro partners with Amgen to study barriers to obesity care, GLP-1 access - Yahoo News Canada

Amgen Inc. $AMGN Shares Acquired by PKO Investment Management Joint Stock Co

GRIMES & Co WEALTH MANAGEMENT LLC Trims Position in Amgen Inc. $AMGN

Amgen Inc. $AMGN Shares Bought by Citizens Financial Group Inc. RI

Bogart Wealth LLC Sells 4,211 Shares of Amgen Inc. $AMGN

Amgen Calls 2026 a "Springboard Year" as CEO Flags Major Data, MariTide Phase 3 Push at JPM Event

Amgen says MariTide helped trial patients maintain weight loss - Yahoo News Canada

Amgen to announce data on obesity drug MariTide at healthcare conference

Amgen Inc. $AMGN Shares Sold by Sumitomo Mitsui Trust Group Inc.

Amgen Buys U.K. Biotech Company

Tema Etfs LLC Boosts Stock Position in Amgen Inc. $AMGN - Daily Political

How Amgen's DISCO Oncology Licensing Deal Will Impact Amgen (AMGN) Investors

Nepsis Inc. Cuts Stock Position in Amgen Inc. $AMGN

Is It Time To Reassess Amgen (AMGN) After Its 28% One Year Share Price Gain?

State of Alaska Department of Revenue Sells 3,034 Shares of Amgen Inc. $AMGN - Stock Observer

Amgen Inc. $AMGN Stock Holdings Reduced by Nova R Wealth Inc. - Stock Observer

Amgen (NASDAQ:AMGN) Upgraded by UBS Group to "Strong-Buy" Rating - Stock Observer

Amgen (AMGN) Valuation Check After DISCO Oncology Deal And Fresh Analyst Optimism

Amgen (NASDAQ:AMGN) Price Target Raised to $319.00 at Truist Financial

Should Amgen's (AMGN) Exclusive DISCO Oncology Deal Require Action From Investors?

Amgen Inc. $AMGN Shares Acquired by HB Wealth Management LLC

Amgen Inc. $AMGN Shares Acquired by Benjamin Edwards Inc.

Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE C

Industry considering options amid US vaccine upheaval | BioWorld

Amgen's $840 Million Acquisition of Dark Blue Therapeutics Boosts Cancer Drug Development, ETPharma

Why India Decided to Sharply Hike Its Tobacco Taxes: Prognosis

CX Institutional Increases Stake in Amgen Inc. $AMGN

Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.52

Cerity Partners LLC Sells 6,837 Shares of Amgen Inc. $AMGN

Securian Asset Management Inc. Lowers Holdings in Amgen Inc. $AMGN - Daily Political

Horizon scanning from panel discussions at the EUGOGO Global TED Forum 2025 London

Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study

Amgen buys Dark Blue Therapeutics for up to $840m

Amgen Buys Cancer Drug Developer Dark Blue in $840 Million Deal

What to Expect From Amgen's Q4 2025 Earnings Report

D.A. Davidson & CO. Purchases 6,222 Shares of Amgen Inc. $AMGN

AMGN: Patent Expiries And New Drug Launches Will Shape Future Performance

Asset Management One Co. Ltd. Buys 9,753 Shares of Amgen Inc. $AMGN

Davis Capital Management Makes New Investment in Amgen Inc. $AMGN

Amgen Inc. $AMGN Shares Bought by Verity & Verity LLC

Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial

SteelPeak Wealth LLC Sells 52,953 Shares of Amgen Inc. $AMGN

Mattern Capital Management LLC Buys 4,411 Shares of Amgen Inc. $AMGN

Amgen Inc. $AMGN Shares Sold by Miracle Mile Advisors LLC

Amgen Inc. $AMGN Shares Acquired by Hofer & Associates. Inc - Markets Daily

VIRGINIA RETIREMENT SYSTEMS ET Al Sells 7,600 Shares of Amgen Inc. $AMGN - Markets Daily

Amgen Inc. $AMGN Shares Bought by Ascent Group LLC

VIRGINIA RETIREMENT SYSTEMS ET Al Decreases Stock Holdings in Amgen Inc. $AMGN - Stock Observer

Amgen Inc. $AMGN Stock Position Trimmed by Oak Asset Management LLC - Markets Daily

Amgen Inc. $AMGN Shares Acquired by Calamos Wealth Management LLC

Boston Trust Walden Corp Lowers Holdings in Amgen Inc. $AMGN

Strong Results and Pipeline Momentum Power Amgen's (AMGN) 2025 Rally

What They Said: Sarah Friar of OpenAI on AI

Argus Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock

14 Best Pharma Dividend Stocks to Buy in 2026

Amgen Inc. $AMGN Shares Acquired by SS&H Financial Advisors Inc.

KW Wealth Management LLC Makes New $437,000 Investment in Amgen Inc. $AMGN - Daily Political

Amgen Inc. $AMGN Shares Sold by Meyer Handelman Co.

Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO

Amgen Inc. $AMGN Stock Holdings Lowered by Pacer Advisors Inc. - Zolmax

Amgen Inc. $AMGN Stake Reduced by Pacer Advisors Inc.

Avanza Fonder AB Purchases 4,546 Shares of Amgen Inc. $AMGN

Regent Peak Wealth Advisors LLC Invests $539,000 in Amgen Inc. $AMGN - Stock Observer

Secured Retirement Advisors LLC Sells 2,459 Shares of Amgen Inc. $AMGN - Stock Observer

Does FDA's UPLIZNA gMG Expansion Reshape the Bull Case for Amgen's Diversification Story (AMGN)?

Farther Finance Advisors LLC Buys 3,158 Shares of Amgen Inc. $AMGN

Amgen Inc. $AMGN Shares Sold by Alpine Woods Capital Investors LLC

Weekly Analysts' Ratings Updates for Amgen (AMGN) - Stock Observer

Amgen Inc. $AMGN Shares Bought by Global X Japan Co. Ltd.

Swedbank AB Sells 283,479 Shares of Amgen Inc. $AMGN - Daily Political

Head to Head Contrast: Amgen (NASDAQ:AMGN) & Dynavax Technologies (NASDAQ:DVAX) - Daily Political

Is There Still Value in Amgen After Its Strong 2025 Share Price Run?

Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial

Amgen Inc. (NASDAQ:AMGN) Receives Consensus Rating of "Moderate Buy" from Analysts

TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers

Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myeloma

Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial

Top Medical Stocks To Follow Today - December 21st - Markets Daily

Assessing Amgen (AMGN) Valuation After UPLIZNA Approval and New U.S. Drug Pricing Agreements

Amgen Inc. $AMGN Shares Purchased by Foster Victor Wealth Advisors LLC

Amgen Inc. $AMGN Shares Sold by CHICAGO TRUST Co NA

Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastases

Trump secures agreements with Merck, Amgen, Novartis and others to cut drug prices under Medicaid

AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COS

Takeda's AI-Driven Psoriasis Pill Shows Promising Results in Late-Stage Trials, ETPharma

Genomic and transcriptomic analyses of aortic stenosis enhance therapeutic target discovery and disease prediction

Amgen Inc. $AMGN Stock Holdings Lessened by Assenagon Asset Management S.A.

Czech National Bank Acquires 5,299 Shares of Amgen Inc. $AMGN - Daily Political

Amgen (AMGN) Valuation Check After FDA Expansion of UPLIZNA in Generalized Myasthenia Gravis

HSBC Turns More Bullish on Amgen (AMGN) into 2026

This biotech name is evolving into a major obesity play. How to trade it with options

Amgen Inc. $AMGN Shares Sold by Fragasso Financial Advisors Inc

Amgen (AMGN) Price Target Trimmed at Morgan Stanley as Policy Risks Ease

Reichman Jorgensen Adds Snell & Wilmer's Mammen to DC Office

What Amgen (AMGN)'s Expanded UPLIZNA Approval in Generalized Myasthenia Gravis Means For Shareholders - Simply Wall St News

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Stock Market Today: S&P 500 and Dow Reach New High On Trump’s Tariff Policy

The Week Ahead: ISM services, SMCI

Week ahead: RBA meeting, Uber earnings, and PMIs

Week ahead: Earnings season climax

Week ahead: Fed, Bank of England seen on pause; Apple earnings

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk